Camp4 Therapeutics Corp
Camp4 Therapeutics Corp
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||
Assets Current | |||||||||||||
Cash And Cash Equivalents At Carrying Value | 86 | 99 | 110 | 75 | 39 | 49 | 64 | 3 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | 1 | |||||
Restricted Cash Current | 1 | 1 | 1 | - | - | - | 0 | - | |||||
Prepaid Expense And Other Assets Current | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | |||||
Assets Current | 90 | 102 | 114 | 78 | 41 | 52 | 66 | 6 | |||||
Restricted Cash Noncurrent | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | |||||
Deferred Costs | - | - | - | - | - | - | - | 3 | |||||
Property Plant And Equipment Net | - | - | - | 3 | 3 | 4 | 4 | - | |||||
Property Plant And Equipment And Finance Lease Rig… | - | 2 | 2 | - | - | - | 4 | - | |||||
Operating Lease Right Of Use Asset | 1 | 0 | 0 | 4 | 5 | 6 | 6 | 6 | |||||
Finance Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 1 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Assets | 93 | 105 | 118 | 86 | 51 | 63 | 78 | 21 | |||||
Liabilities And Stockhold… | |||||||||||||
Liabilities | |||||||||||||
Liabilities Current | |||||||||||||
Accounts Payable Current | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 4 | |||||
Accrued Liabilities Current | 4 | 4 | 6 | 4 | 3 | 2 | 5 | 4 | |||||
Contract With Customer Liability Current | 13 | 11 | 9 | 0 | 0 | 0 | 0 | 1 | |||||
Operating Lease Liability Current | 1 | 0 | 0 | 3 | 3 | 3 | 3 | 3 | |||||
Finance Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Current | - | - | 0 | - | - | - | 0 | - | |||||
Liabilities Current | 19 | 17 | 16 | 8 | 7 | 6 | 10 | 12 | |||||
Liabilities Noncurrent | |||||||||||||
Contract With Customer Liability Noncurrent | 2 | 5 | 8 | - | - | - | 0 | - | |||||
Operating Lease Liability Noncurrent | 2 | 2 | 2 | 3 | 4 | 5 | 5 | 6 | |||||
Finance Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Derivative Liabilities Noncurrent | 72 | 51 | 45 | 17 | - | - | 0 | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Liabilities | 94 | 75 | 70 | 28 | 11 | 11 | 15 | 18 | |||||
Equity | |||||||||||||
Stockholders Equity | |||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 343 | 341 | 340 | 311 | 277 | 276 | 275 | 39 | |||||
Retained Earnings Accumulated Deficit | -344 | -310 | -292 | -252 | -237 | -224 | -212 | -198 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | 0 | - | - | - | 0 | 162 | |||||
Stockholders Equity | -1 | 31 | 48 | 59 | 40 | 52 | 63 | -159 | |||||
Liabilities And Stockholders Equity | 93 | 105 | 118 | 86 | 51 | 63 | 78 | 21 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 175 | 175 | 175 | 175 | 175 | 175 | 175 | 175 | |||||
Common Stock Shares Issued | 52 | 52 | 52 | 47 | 20 | 20 | 20 | 1 | |||||
Shares Outstanding | 52 | 52 | 52 | 47 | 20 | 20 | 20 | 1 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0 | 0 | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | - | 25 | 150 | |||||
Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | 131 | |||||
Temporary Equity Shares Outstanding | - | - | 0 | - | - | - | 0 | 131 | |||||
Temporary Equity Liquidation Preference | - | - | - | - | - | - | 0 | 163 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.15% | -3.23% | -27.19% | - | - | - | - | - | - | - | - | - |
| 2025 | -4.95% | -29.21% | -18.32% | -1.94% | 95.48% | 168.39% | -14.61% | 33.93% | -9.89% | -6.10% | -3.27% | -1.74% |
| 2024 | - | - | - | - | - | - | 32.01% | -29.76% | -24.39% | -55.20% | -47.96% | -65.16% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Camp4 Therapeutics Corp (CAMP) — SEC Financial Statements & Analysis
Camp4 Therapeutics Corp (CAMP) is a pharmaceutical preparations company, incorporated in DE. Camp4 Therapeutics Corp trades on Nasdaq as: CAMP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Camp4 Therapeutics Corp reported a 40.21% year-over-year revenue growth, a Debt-to-Equity ratio of -135.82x, a Price-to-Sales (P/S) ratio of 60.05x (TTM), a Price-to-Book (P/B) ratio of -365.30x (TTM), at a market cap of $253.15M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 40.21%
- Debt To Equity
- -135.82x
- P/S TTM
- 60.05x
- P/B TTM
- -365.30x
- Market Cap
- $253.15M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Camp4 Therapeutics Corp in?
Camp4 Therapeutics Corp (CAMP) operates in the Pharmaceutical Preparations industry.
What is CAMP's market cap?
Camp4 Therapeutics Corp (CAMP) has a market capitalization of $253.15M as of 2026-06-30.
What exchange does CAMP trade on?
Camp4 Therapeutics Corp (CAMP) trades on the Nasdaq.
Where is Camp4 Therapeutics Corp incorporated?
Camp4 Therapeutics Corp is incorporated in DE.